These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 8212369)
1. [Severe obstructive lung disease. The effect of the calcium antagonist isradipine on working capacity, pulmonary function, morbidity and survival]. Petersen JR; Galløe AM; Graudal NA; Galløe M Ugeskr Laeger; 1993 Aug; 155(34):2612-5. PubMed ID: 8212369 [TBL] [Abstract][Full Text] [Related]
2. The effect of the calcium antagonist, isradipine, on working capacity, pulmonary function, morbidity and survival rate in patients with severe chronic obstructive pulmonary disease (COPD): a randomized, double-blind, placebo-controlled study. Galløe AM; Graudal N; Petersen JR; Leth P; Galløe M J Intern Med; 1991 May; 229(5):447-52. PubMed ID: 1828266 [TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic peptide (ANP) in chronic obstructive pulmonary disease (COPD): the relationship between plasma ANP and lung function. Effects of exercise and of the calcium antagonist, isradipine, on plasma ANP. A randomised, double-blind, placebo-controlled study. Graudal N; Galløe AM; Storm T; Thamsborg G; Christensen HR Horm Metab Res; 1992 Mar; 24(3):130-3. PubMed ID: 1533606 [TBL] [Abstract][Full Text] [Related]
4. [Modification of pulmonary hypertension in patients with chronic obstructive lung diseases by trapidil (Rocornal) in an acute trial]. Schauer J; Orschekowski H; Winkler J; Steiniger L Z Erkr Atmungsorgane; 1991; 177(3):204-16. PubMed ID: 1808871 [TBL] [Abstract][Full Text] [Related]
5. [The long-term effect of nifedipine (control release tablets) in patients with chronic obstructive pulmonary disease and cor pulmonale]. Cheng X; Yao Z; Li Q Zhonghua Jie He He Hu Xi Za Zhi; 1997 Apr; 20(2):84-7. PubMed ID: 10072830 [TBL] [Abstract][Full Text] [Related]
6. [Long-term effect of inhaled budesonide in patients with mild to moderate chronic obstructive lung disease. The Osterbro Study]. Vestbo J; Sørensen T; Lange P; Brix A; Torre P; Viskum K Ugeskr Laeger; 2000 Jan; 162(4):493-7. PubMed ID: 10697447 [TBL] [Abstract][Full Text] [Related]
7. [The effect of salmeterol in the treatment of smokers with chronic obstructive lung disease]. Ulrik CS Ugeskr Laeger; 1996 Jun; 158(25):3604-7. PubMed ID: 8693619 [TBL] [Abstract][Full Text] [Related]
8. [The effect of isradipine on the central and cerebral hemodynamics of patients with circulatory encephalopathy and hypertension]. Lepakhin VK; Ivleva AIa; Romashova MF; Udotova SA; Zubovskiĭ LG Eksp Klin Farmakol; 1992; 55(6):24-6. PubMed ID: 1305868 [TBL] [Abstract][Full Text] [Related]
9. Short-term effects of montelukast in stable patients with moderate to severe COPD. Celik P; Sakar A; Havlucu Y; Yuksel H; Turkdogan P; Yorgancioglu A Respir Med; 2005 Apr; 99(4):444-50. PubMed ID: 15763450 [TBL] [Abstract][Full Text] [Related]
10. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD. Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763 [TBL] [Abstract][Full Text] [Related]
12. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension. Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383 [TBL] [Abstract][Full Text] [Related]
13. The role of domiciliary nebulizers in managing patients with severe COPD. Eiser N; Angus K; McHale S Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108 [TBL] [Abstract][Full Text] [Related]
14. Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease. Ferguson MK; Vigneswaran WT Ann Thorac Surg; 2008 Apr; 85(4):1158-64; discussion 1164-5. PubMed ID: 18355489 [TBL] [Abstract][Full Text] [Related]
15. Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil. Adnot S; Samoyeau R; Weitzenblum E Blood Press Suppl; 1995; 3():47-57. PubMed ID: 8535542 [TBL] [Abstract][Full Text] [Related]
16. [Mortality due to chronic obstructive bronchopneumopathies]. Tschopp JM Schweiz Med Wochenschr; 1993 Feb; 123(5):170-4. PubMed ID: 8438139 [TBL] [Abstract][Full Text] [Related]
17. Erythropoietin in chronic obstructive pulmonary disease. Relationship between serum erythropoietin, blood hemoglobin and lung function--effect of the calcium antagonist isradipine on serum erythropoietin. Graudal N; Galløe AM; Nielsen OJ Respiration; 1991; 58(3-4):141-4. PubMed ID: 1836066 [TBL] [Abstract][Full Text] [Related]
18. [Antihypertensive effect and adverse effects of isradipine in patients with sever hypertension. Results of an open multicenter study]. Burger KJ; Dehner R Arzneimittelforschung; 1996 Jun; 46(6):600-5. PubMed ID: 8767350 [TBL] [Abstract][Full Text] [Related]
19. Acute effects of nifedipine administration in pulmonary haemodynamics and oxygen delivery during exercise in patients with chronic obstructive pulmonary disease: implication of the angiotensin-converting enzyme gene polymorphisms. Kanazawa H; Tateishi Y; Yoshikawa J Clin Physiol Funct Imaging; 2004 Jul; 24(4):224-8. PubMed ID: 15233837 [TBL] [Abstract][Full Text] [Related]
20. [Pulmonary hemodynamic monitoring in chronic respiratory insufficiency treated with almitrine bismesilate for 4 months in a double-blind study]. Bourgouin-Karaouni D; Ramonatxo M; Michel FB; Macabies J; Prefaut C Rev Mal Respir; 1984; 1(4):245-50. PubMed ID: 6505362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]